<DOC>
	<DOCNO>NCT00286377</DOCNO>
	<brief_summary>This double-blind , placebo-controlled , parallel group study determine whether prosptide effective relieving pain patient sensory neuropathic pain related HIV infection drug use treat .</brief_summary>
	<brief_title>Safety Efficacy Study Prosaptide Treat Neuropathic Pain HIV-Positive Patients</brief_title>
	<detailed_description>Sensory neruopathies frequent neurological complicaton HIV infection treatmet antiretrovirals . To date , effective treatment , symptomatic treatment pain . Management typically involve intiation adjustment pain-modifying therapy , adjustment discontinuation potentially neurotoxic antiretrovirals , thereby limit choice HAART regimens . In precinical animal model , prosaptide show efficacious treatment neuropathic pain cause variety different mechanism . Hypothesis : Prosaptide improve neuropathic pain HIV-associated sensory neuroathies , safe well tolerated subject . Comparisons : 4 , 8 , 16 mg prosaptide vs. placebo</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>Ages 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>